about
Increased Circulating T Lymphocytes Expressing HLA-DR in Kidney Transplant Recipients with Microcirculation Inflammation.Vitamin D deficiency is associated with increased risk of bacterial infections after kidney transplantationFree thyroxine level as an independent predictor of infection-related mortality in patients on peritoneal dialysis: a prospective multicenter cohort study.Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.The Korean Clinical Research Center for End-Stage Renal Disease Study Validates the Association of Hemoglobin and Erythropoiesis-Stimulating Agent Dose with Mortality in Hemodialysis Patients.Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-β1-Induced Epithelial Mesenchymal Transition.A case of transient central diabetes insipidus after aorto-coronary bypass operationImpact of dialysis modality on technique survival in end-stage renal disease patients.Impact of gene polymorphisms of interleukin-18, transforming growth factor-β, and vascular endothelial growth factor on development of IgA nephropathy and thin glomerular basement membrane diseaseA Study of Core Humanistic Competency for Developing Humanism Education for Medical Students.Depressive Symptoms, Patient Satisfaction, and Quality of Life Over Time in Automated and Continuous Ambulatory Peritoneal Dialysis Patients: A Prospective Multicenter Propensity-Matched StudyImmunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.Encapsulating peritoneal sclerosis: case series from a university center.Duration of anuria predicts recovery of renal function after acute kidney injury requiring continuous renal replacement therapy.Low prealbumin levels are independently associated with higher mortality in patients on peritoneal dialysis.Nafamostat Mesilate as an Anticoagulant During Continuous Renal Replacement Therapy in Patients With High Bleeding Risk: A Randomized Clinical Trial.Metabolomics Study for Identification of Potential Biomarkers of Long-term Survival in Kidney Transplantation Recipients.A Real-world Cost-effectiveness Analysis of Sevelamer Versus Calcium Acetate in Korean Dialysis Patients.Cystatin C-Based Equation for Predicting the Glomerular Filtration Rate in Kidney Transplant Recipients.Clinical impact of BK virus surveillance on outcomes in kidney transplant recipients.Rhabdomyolysis associated with cytomegalovirus infection in kidney transplant recipients.Low serum phosphate as an independent predictor of increased infection-related mortality in dialysis patients: A prospective multicenter cohort study.Efficacy and safety of a balanced salt solution versus a 0.9% saline infusion for the prevention of contrast-induced acute kidney injury (BASIC trial): a study protocol for a randomized controlled trial.The efficacy and stability of an information and communication technology-based centralized monitoring system of adherence to immunosuppressive medication in kidney transplant recipients: study protocol for a randomized controlled trialThe Effect of Mycophenolate Mofetil versus Cyclosporine as Combination Therapy with Low Dose Corticosteroids in High-risk Patients with Idiopathic Membranous Nephropathy: a Multicenter Randomized Trial.HLA gene dosage effect on renal allograft survival.Usefulness of mycophenolic acid monitoring with PETINIA for prediction of adverse events in kidney transplant recipients.Effect of transient post-transplantation hyperglycemia on the development of diabetes mellitus and transplantation outcomes in kidney transplant recipients.Individualized prediction of mortality using multiple inflammatory markers in patients on dialysis.Fimasartan attenuates renal ischemia-reperfusion injury by modulating inflammation-related apoptosisAnti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathyComparison of Transplant Outcomes for Low-level and Standard-level Tacrolimus at Different Time Points after Kidney TransplantationApplication of flow cytometry to measure anti-A/B antibody in ABO-incompatible kidney transplantationChanges in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetesOutcomes of open heart surgery in patients with end-stage renal diseaseDialysis modality-related disparities in sudden cardiac death: hemodialysis versus peritoneal dialysisCharacteristics and Clinical Significance of De Novo Donor-Specific Anti-HLA Antibodies after Kidney TransplantationPatterns in renal diseases diagnosed by kidney biopsy: A single-center experienceOutcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South KoreaMycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients
P50
Q33661464-83AC84C2-6B4D-42FC-BEA7-4E7452A453C0Q33690672-FE8EC7A8-D6F6-463C-ADBA-4CE3D6EE1390Q34599385-2606B2DE-FCE3-44B3-A083-AC6AC3040388Q35742711-A7BB4FA6-A22A-47EB-9C12-57C845569986Q35801832-70D1DBFB-0CF4-4EFA-9AAE-9E2E2158EF8BQ36126662-10285D08-9AB3-424F-9C51-64D7B4FD0A07Q36195705-474CE94C-C596-43B4-A339-954F170CCD15Q36461099-4A987A9B-B356-4F52-88B9-BFE9FC1D8A4FQ36471803-DE861632-7895-4280-A720-EF34BD0BB436Q36859788-711B62E9-8358-484F-9E6E-64D25FF514E1Q36993005-1E1D7EBE-ED78-4EC7-B238-C89F63C5F1B8Q37026155-E4EDF4B8-C966-4011-95E7-5013498AEC60Q37138761-AD331F91-3808-497F-BD71-85EF631A2A28Q37242585-764275E3-3BF6-4CFC-A538-8082246616E9Q37260193-430B0AD0-04F6-45D4-8ED3-35632855555AQ37624247-AB6F64A0-4980-47BF-B7EF-18B46F4F6A62Q38742532-73824FB8-39DD-4AA3-9649-78A41B588237Q38909090-77F5CB6F-3D11-4241-918A-3E1F540AA545Q40172117-07D7FB53-3941-4FE0-8D09-49C2F424ECF4Q41310038-E1E0670C-BA26-4C70-BF6B-E409EFD88AACQ41728131-B44BFB11-4FCB-4189-BB62-53F0235A6E2AQ42369658-674511DA-82B6-4998-BDA9-55C41CDA2B92Q42371254-08F6A784-593B-4908-80B3-34910F6DF942Q42690371-453A5C68-424D-48AB-81E4-9ECCDE4C1793Q50019614-9787A6EB-2028-4FEE-BC2F-918896D057F4Q50562280-5A271D70-969D-4772-BA17-39EFDC0A30C0Q50691259-553A3EA4-42B6-453B-BF02-37C3C6F31BD6Q51032012-DFA6DEDE-BFEE-4039-9502-0F362E450D7EQ53081135-3B1AF664-D66F-47A3-BD93-75094624FAE9Q58565241-9F320DE9-6147-41DA-9D5B-BA03A8CB013DQ58795388-A52C8853-46D5-4207-ACE6-660ACCCF8C35Q64062500-57E2F57B-0A5F-44C4-9A15-09915C18BDC6Q87149102-4D134E30-2598-454D-8187-756070F7E093Q89276365-22E3447D-C39C-4D66-85DF-34CDC0F05EDEQ90263614-960A02D0-D630-4A13-A96E-A2475A9D8F56Q90282172-4B8B7708-A541-4B42-9661-AD32F446AC02Q91050124-BD003960-B4F4-4E96-8CC4-E4765CA4F00BQ92753475-0BFEA7FB-7802-4CD5-85A0-D81496706F2CQ96128107-E6155D3B-22BE-4754-AB03-A59A855D1651Q96610863-41090E3A-5F7D-4E05-89E0-2C9260BBB6EA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hee-Yeon Jung
@ast
Hee-Yeon Jung
@en
Hee-Yeon Jung
@es
Hee-Yeon Jung
@nl
Hee-Yeon Jung
@sl
type
label
Hee-Yeon Jung
@ast
Hee-Yeon Jung
@en
Hee-Yeon Jung
@es
Hee-Yeon Jung
@nl
Hee-Yeon Jung
@sl
prefLabel
Hee-Yeon Jung
@ast
Hee-Yeon Jung
@en
Hee-Yeon Jung
@es
Hee-Yeon Jung
@nl
Hee-Yeon Jung
@sl
P106
P1153
56449799000
P21
P31
P496
0000-0003-0232-7202